Mirati Therapeutics Inc (DELISTED) (MRTX:DL)
58.70
0.00 (0.00%)
USD |
NASDAQ |
Jan 23, 16:00
Mirati Therapeutics Accounts Payable (Quarterly): 37.96M for Sept. 30, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 37.96M |
June 30, 2023 | 32.51M |
March 31, 2023 | 22.32M |
December 31, 2022 | 38.86M |
September 30, 2022 | 19.45M |
June 30, 2022 | 24.27M |
March 31, 2022 | 27.94M |
December 31, 2021 | 35.16M |
September 30, 2021 | 42.92M |
June 30, 2021 | 23.87M |
March 31, 2021 | 19.60M |
December 31, 2020 | 18.12M |
September 30, 2020 | 15.98M |
June 30, 2020 | 24.10M |
March 31, 2020 | 9.587M |
December 31, 2019 | 16.37M |
September 30, 2019 | 12.57M |
June 30, 2019 | 10.51M |
March 31, 2019 | 10.07M |
December 31, 2018 | 8.531M |
September 30, 2018 | 6.843M |
June 30, 2018 | 4.266M |
March 31, 2018 | 4.731M |
December 31, 2017 | 4.344M |
September 30, 2017 | 2.729M |
Date | Value |
---|---|
June 30, 2017 | 3.973M |
March 31, 2017 | 3.45M |
December 31, 2016 | 6.296M |
September 30, 2016 | 3.211M |
June 30, 2016 | 4.445M |
March 31, 2016 | 3.236M |
December 31, 2015 | 2.104M |
September 30, 2015 | 3.248M |
June 30, 2015 | 1.813M |
March 31, 2015 | 1.271M |
December 31, 2014 | 1.655M |
September 30, 2014 | 1.934M |
June 30, 2014 | 0.963M |
March 31, 2014 | 0.546M |
December 31, 2013 | 1.302M |
September 30, 2013 | 2.001M |
June 30, 2013 | 1.405M |
March 31, 2013 | 1.197M |
December 31, 2012 | 1.752M |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | 0.763M |
September 30, 2011 | |
June 30, 2011 |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
9.587M
Minimum
Mar 2020
42.92M
Maximum
Sep 2021
24.00M
Average
23.09M
Median
Accounts Payable (Quarterly) Benchmarks
Bristol-Myers Squibb Co | 3.539B |
Karuna Therapeutics Inc (DELISTED) | 6.783M |
Puma Biotechnology Inc | 8.964M |
NovaBay Pharmaceuticals Inc | 1.117M |
Palatin Technologies Inc | 3.443M |